Premium
Sonographic monitoring of ovarian volume during LHRH analogue therapy in women with polycystic ovarian syndrome.
Author(s) -
Jaffe R,
Abramowicz J,
Eckstein N,
Vagman I,
Fejgin M,
Ayalon D
Publication year - 1988
Publication title -
journal of ultrasound in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.574
H-Index - 91
eISSN - 1550-9613
pISSN - 0278-4297
DOI - 10.7863/jum.1988.7.4.203
Subject(s) - medicine , ovarian hyperstimulation syndrome , polycystic ovarian disease , ovulation , ovulation induction , infertility , incidence (geometry) , polycystic ovary , gonadotropin , gynecology , ovary , controlled ovarian hyperstimulation , endocrinology , hormone , in vitro fertilisation , pregnancy , obesity , insulin resistance , biology , genetics , physics , optics
Polycystic ovarian disease is characterized by menstrual disorders, infertility, obesity, and large ovaries. Large ovaries with multiple cysts are the direct cause of the high incidence of ovarian hyperstimulation during ovulation induction. Lately, gonadotropin‐releasing hormone (GnRH) analogues have been employed to decrease ovarian steroidogenesis and thus reduce the incidence of ovarian hyperstimulation. In this study the ovarian size was ultrasonographically assessed during chronic GnRH analogue treatment, revealing a significant reduction in ovarian volume. This decrease in volume results in a reduced incidence of hyperstimulation, and we think the ultrasonic scanning can be effectively used to assess the success of GnRH treatment.